Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,051,906 | 9,426,833 | 13,418,650 | 11,946,940 | 15,895,100 |
| Receivables | 9,090,722 | 9,550,216 | 9,269,572 | 9,677,759 | 8,556,970 |
| Inventories | 10,205,290 | 10,461,510 | 9,440,256 | 10,310,720 | 9,540,489 |
| Other current assets | 18,736,562 | 3,755,581 | 3,721,312 | 4,224,851 | 4,506,381 |
| TOTAL | $46,084,480 | $33,194,140 | $35,849,790 | $36,160,270 | $38,498,940 |
| Non-Current Assets | |||||
| PPE Net | 10,919,470 | 10,996,170 | 10,397,980 | 11,864,130 | 10,697,640 |
| Investments And Advances | 341,944 | 458,895 | 713,287 | 295,775 | 229,602 |
| Intangibles | 71,432,670 | 79,790,400 | 75,366,110 | 82,181,670 | 71,719,310 |
| Other Non-Current Assets | 14,922,156 | 12,432,435 | 11,187,123 | 11,756,425 | 9,680,988 |
| TOTAL | $97,616,240 | $103,677,900 | $97,664,500 | $106,098,000 | $92,327,540 |
| Total Assets | $143,700,700 | $136,872,000 | $133,514,300 | $142,258,300 | $130,826,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,554,559 | 2,213,303 | 4,397,727 | 3,765,807 | 3,160,744 |
| Accounts payable and accrued liabilities | 8,170,937 | 7,931,094 | 7,178,177 | 7,311,558 | 6,048,479 |
| Other current liabilities | 15,488,100 | 15,097,000 | 12,775,950 | 13,432,920 | 11,822,800 |
| TOTAL | $31,556,200 | $26,185,170 | $25,248,470 | $25,194,120 | $21,986,990 |
| Non-Current Liabilities | |||||
| Long Term Debt | 12,759,040 | 15,527,760 | 15,653,330 | 20,258,220 | 22,554,710 |
| Other Non-Current Liabilities | 12,729,829 | 12,638,016 | 11,373,615 | 13,156,073 | 12,088,956 |
| TOTAL | $27,895,460 | $30,214,570 | $29,085,680 | $35,393,620 | $36,706,660 |
| Total Liabilities | $59,451,660 | $56,399,730 | $54,334,150 | $60,587,730 | $58,693,660 |
| Shareholders' Equity | |||||
| Common Shares | 2,733,385 | 2,738,219 | 2,657,179 | 2,989,694 | 2,876,311 |
| Retained earnings | 73,782,990 | 73,054,160 | 70,310,950 | 74,550,680 | 68,590,550 |
| Other shareholders' equity | 8,641,685 | 5,622,111 | 6,824,321 | 4,611,797 | 1,057,446 |
| TOTAL | $84,249,060 | $80,472,250 | $79,180,150 | $81,670,580 | $72,132,820 |
| Total Liabilities And Equity | $143,700,720 | $136,871,980 | $133,514,300 | $142,258,310 | $130,826,480 |